Preliminary findings of a phase I dose-escalation study of sunitinib in combination with gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Reck, M. [1 ]
Frickhofen, N. [2 ]
Gatzemeier, U. [1 ]
Fuhr, H. G. [2 ]
Lanzalone, S. [3 ]
Wang, E. [4 ]
Chao, R. [4 ]
Felip, E. [5 ]
机构：
[1] Hosp Grosshansdorf, Dept Thorac Oncol, Grosshansdorf, Germany
[2] Dr Horst Schmidt Klin, Wiesbaden, Germany
[3] Pfizer Italia, Milan, Italy
[4] Pfizer Inc, Global Res & Dev, La Jolla, CA USA
[5] Vall Hebron Univ Hosp, Dept Oncol, Barcelona, Spain
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71435-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6607
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [31] Phase I/II Study of Gemcitabine and Vinorelbine Plus Cisplatin in Non-Small Cell Lung Cancer
    Emilio Esteban
    Joaquín Fra
    Marian Sala
    Juan Carrasco
    Norberto Corral
    José María Vieitez
    Enrique Estrada
    Isabel Palacio
    José Marí Buesa
    Angel J. Lacave
    Investigational New Drugs, 2002, 20 : 317 - 326
  • [32] Phase I dose-escalation study of sorafenib in combination with bevacizumab (B), paclitaxel (P), and carboplatin (C) for the treatment of advanced nonsquamous non-small cell lung cancer (NSCLC).
    Blumenschein, G. R.
    Molina, J. R.
    Lathia, C. D.
    Ong, T. J.
    Roth, D.
    Rajagopalan, P.
    Fossella, F. V.
    Kies, M. S.
    Marks, R. S.
    Adjei, A. A.
    Sundaresan, P. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] Gemcitabine plus cisplatin in non-small cell lung cancer: A Phase II study
    Sandler, A
    Ansari, R
    McClean, J
    Fisher, W
    Dorr, FA
    Einhorn, LH
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1079 - 1079
  • [34] Cisplatin, Gemcitabine and paclitaxel in advanced non-small cell lung cancer. A phase I study
    Comella, P
    Frasci, G
    Panza, N
    Lorusso, V
    Nicolella, GP
    Natale, M
    Manzione, L
    Bilancia, D
    Cioffi, R
    Maiorino, L
    Apicella, A
    Gravina, A
    Ruffolo, P
    De Rosa, V
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 91
  • [35] Results of high dose of gemcitabine plus cisplatin combination in metastatic non-small cell lung cancer
    Mayadagli, A
    Cepni, K
    Ozkan, A
    Ozseker, N
    Tepetam, H
    LUNG CANCER, 2005, 49 : S258 - S258
  • [36] A dose-escalation study of vorinostat in combination with radiotherapy for patients with non-small cell lung cancer
    Decker, R. H.
    Gettinger, S. N.
    Wilson, L. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: A phase II study
    Bretti, S
    Manzin, E
    Loddo, C
    Berruti, A
    Bombaci, S
    Vellani, G
    Celano, A
    ANTICANCER RESEARCH, 2002, 22 (05) : 3039 - 3043
  • [38] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Manegold, C.
    Digumarti, R.
    Zukin, M.
    de Marinis, F.
    Mellerngaard, A.
    Gandara, D.
    Simms, L.
    Kaiser, C.
    Blatter, J.
    Gatzemeier, U.
    EJC SUPPLEMENTS, 2007, 5 (06): : 9 - 9
  • [39] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Scagliotti, Giorgio
    Purvish, Parikh
    von Pawel, Joachim
    Biesma, Bonna
    Vansteenkiste, Johan
    Manegold, Christian
    Simms, Lorinda
    Posther, Sugarman Katherine
    Obasaju, Coleman
    Blatter, Johannes
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S306 - S306
  • [40] A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer
    Ullenhag, Gustav J.
    Rossmann, Eva
    Liljefors, Maria
    PLOS ONE, 2015, 10 (04):
12345